Page last updated: 2024-11-03

riluzole and Amyloid Deposits

riluzole has been researched along with Amyloid Deposits in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Mazumder, S1
McCann, H1
D'Silva, S1
Furlong, S1
Shepherd, CE1
Kril, JJ1
Halliday, GM1
Rowe, DB1
Kiernan, MC1
Tan, RH1
Okamoto, M1
Gray, JD1
Larson, CS1
Kazim, SF1
Soya, H1
McEwen, BS1
Pereira, AC1

Other Studies

2 other studies available for riluzole and Amyloid Deposits

ArticleYear
Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis.
    Brain : a journal of neurology, 2023, 03-01, Volume: 146, Issue:3

    Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Pl

2023
Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer's disease.
    Translational psychiatry, 2018, 08-14, Volume: 8, Issue:1

    Topics: Alzheimer Disease; Animals; Astrocytes; Cognition; Disease Models, Animal; Gene Expression; Hippocam

2018